[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Rosuvastatin.]
[J01EC02, sulfadiazine, The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Rosuvastatin.]
[S01AB01, sulfamethizole, The metabolism of Rosuvastatin can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Rosuvastatin.]
[J01EC03, sulfamoxole, The metabolism of Rosuvastatin can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Rosuvastatin can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Rosuvastatin can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Rosuvastatin.]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be increased when used in combination with Rosuvastatin.]
[A10BC01, glymidine, The therapeutic efficacy of Glymidine can be increased when used in combination with Rosuvastatin.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Rosuvastatin.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Rosuvastatin.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Rosuvastatin.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Rosuvastatin.]
[G03BA03, testosterone, The metabolism of Rosuvastatin can be increased when combined with Testosterone.]
[S03AA02, tetracycline, The excretion of Rosuvastatin can be decreased when combined with Tetracycline.]
[A04AD10, dronabinol, The metabolism of Rosuvastatin can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The metabolism of Rosuvastatin can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, The metabolism of Rosuvastatin can be increased when combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Rosuvastatin.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Rosuvastatin.]
[B01AC05, ticlopidine, The metabolism of Rosuvastatin can be decreased when combined with Ticlopidine.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be increased when used in combination with Rosuvastatin.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be increased when used in combination with Rosuvastatin.]
[N06AF04, tranylcypromine, The metabolism of Rosuvastatin can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The metabolism of Rosuvastatin can be decreased when combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Rosuvastatin can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Rosuvastatin.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Rosuvastatin.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Rosuvastatin.]
[R03BA07, mometasone, The metabolism of Rosuvastatin can be increased when combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Rosuvastatin can be decreased when combined with Trimethadione.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Trimethaphan.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Rosuvastatin.]
[N06AA06, trimipramine, The metabolism of Rosuvastatin can be decreased when combined with Trimipramine.]
[J01FA08, troleandomycin, The metabolism of Rosuvastatin can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Rosuvastatin.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Rosuvastatin.]
[A10BH05, linagliptin, The metabolism of Rosuvastatin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The serum concentration of Rosuvastatin can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Rosuvastatin can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Rosuvastatin.]
[B01AC24, ticagrelor, The metabolism of Rosuvastatin can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Rosuvastatin can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Rosuvastatin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Rosuvastatin.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Rosuvastatin.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Rosuvastatin.]
[A11HA03, vitamin E, The metabolism of Rosuvastatin can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Rosuvastatin.]
[J05AF01, zidovudine, The excretion of Rosuvastatin can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Rosuvastatin.]
[J05AE02, indinavir, The metabolism of Rosuvastatin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Rosuvastatin.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Rosuvastatin.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Rosuvastatin.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Rosuvastatin.]
[R03DC01, zafirlukast, The metabolism of Rosuvastatin can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Rosuvastatin.]
[N05AE04, ziprasidone, The metabolism of Rosuvastatin can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, Rosuvastatin may decrease the excretion rate of Drospirenone which could result in a higher serum level.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Rosuvastatin.]
[G04BD07, tolterodine, The metabolism of Rosuvastatin can be decreased when combined with Tolterodine.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Rosuvastatin.]
[C07AB03, atenolol, Atenolol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J02AC03, voriconazole, The metabolism of Rosuvastatin can be decreased when combined with Voriconazole.]
[S01FA01, atropine, Atropine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Rosuvastatin.]
[R07AX02, ivacaftor, The metabolism of Rosuvastatin can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Rosuvastatin can be increased when combined with Prednylidene.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Rosuvastatin.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Rosuvastatin.]
[V03AX03, cobicistat, The metabolism of Rosuvastatin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Rosuvastatin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Rosuvastatin can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Rosuvastatin.]
[L04AA31, teriflunomide, The serum concentration of Rosuvastatin can be increased when it is combined with Teriflunomide.]
[A02AA05, magnesium silicate, Magnesium silicate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AC02, calcium silicate, Calcium silicate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Rosuvastatin.]
[N05CA04, barbital, The metabolism of Rosuvastatin can be increased when combined with Barbital.]
[J05AE04, nelfinavir, The metabolism of Rosuvastatin can be decreased when combined with Nelfinavir.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Rosuvastatin.]
[N06DA02, donepezil, The metabolism of Rosuvastatin can be decreased when combined with Donepezil.]
[N03AX22, perampanel, The metabolism of Rosuvastatin can be increased when combined with Perampanel.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Rosuvastatin.]
[H01CB05, pasireotide, The metabolism of Rosuvastatin can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Rosuvastatin.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Rosuvastatin.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Rosuvastatin.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Rosuvastatin.]
[A10BH04, alogliptin, The therapeutic efficacy of Alogliptin can be increased when used in combination with Rosuvastatin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Rosuvastatin can be increased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Rosuvastatin.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Rosuvastatin.]
[A10BK02, canagliflozin, The therapeutic efficacy of Canagliflozin can be increased when used in combination with Rosuvastatin.]
[M04AB03, benzbromarone, Rosuvastatin may decrease the excretion rate of Benzbromarone which could result in a higher serum level.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Rosuvastatin is combined with Insulin detemir.]
[A10BX05, pramlintide, The therapeutic efficacy of Pramlintide can be increased when used in combination with Rosuvastatin.]
[J02AX04, caspofungin, The excretion of Rosuvastatin can be decreased when combined with Caspofungin.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[C10AC04, colesevelam, Colesevelam can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Rosuvastatin.]
[L01EC02, dabrafenib, The serum concentration of Rosuvastatin can be decreased when it is combined with Dabrafenib.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J05AJ03, dolutegravir, The excretion of Rosuvastatin can be decreased when combined with Dolutegravir.]
[A10BJ03, lixisenatide, The therapeutic efficacy of Lixisenatide can be increased when used in combination with Rosuvastatin.]
[A05AA03, cholic acid, Cholic Acid may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Rosuvastatin.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Rosuvastatin.]
[N03AF04, eslicarbazepine, The metabolism of Rosuvastatin can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The serum concentration of Rosuvastatin can be increased when it is combined with Simeprevir.]
[A10BK01, dapagliflozin, The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Rosuvastatin.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Rosuvastatin.]
[A16AA07, metreleptin, The metabolism of Rosuvastatin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Rosuvastatin can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Rosuvastatin can be increased when combined with Formestane.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Rosuvastatin.]
[C10AB02, bezafibrate, Bezafibrate may increase the myopathic rhabdomyolysis activities of Rosuvastatin.]
[A10BJ04, albiglutide, The therapeutic efficacy of Albiglutide can be increased when used in combination with Rosuvastatin.]
[L04AC11, siltuximab, The metabolism of Rosuvastatin can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Rosuvastatin.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Rosuvastatin.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Rosuvastatin.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Rosuvastatin.]
[N07XX08, tafamidis, The serum concentration of Rosuvastatin can be increased when it is combined with Tafamidis.]
[A10BK03, empagliflozin, The therapeutic efficacy of Empagliflozin can be increased when used in combination with Rosuvastatin.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Rosuvastatin.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Rosuvastatin.]
[J01XA05, oritavancin, The metabolism of Rosuvastatin can be increased when combined with Oritavancin.]
[A10BJ05, dulaglutide, The therapeutic efficacy of Dulaglutide can be increased when used in combination with Rosuvastatin.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Rosuvastatin.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Rosuvastatin.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Rosuvastatin.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Rosuvastatin is combined with Dicoumarol.]
[N06AX11, mirtazapine, The metabolism of Rosuvastatin can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Rosuvastatin can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Rosuvastatin.]
[L01EX08, lenvatinib, Lenvatinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Rosuvastatin.]
[J05AP07, daclatasvir, The serum concentration of Rosuvastatin can be increased when it is combined with Daclatasvir.]
[N02BE01, acetaminophen, The metabolism of Rosuvastatin can be increased when combined with Acetaminophen.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Rosuvastatin is combined with Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Rosuvastatin can be increased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The serum concentration of Rosuvastatin can be increased when it is combined with Eluxadoline.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Rosuvastatin.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A06AD03, magnesium peroxide, Magnesium peroxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10BF01, acarbose, The therapeutic efficacy of Acarbose can be increased when used in combination with Rosuvastatin.]
[S01EC01, acetazolamide, The metabolism of Rosuvastatin can be decreased when combined with Acetazolamide.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Rosuvastatin is combined with Insulin degludec.]
[C10AD06, acipimox, Acipimox may increase the myopathic rhabdomyolysis activities of Rosuvastatin.]
[A02BC03, lansoprazole, The excretion of Rosuvastatin can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The risk or severity of myopathy and rhabdomyolysis can be increased when Rosuvastatin is combined with Trabectedin.]
[J02AC05, isavuconazole, The metabolism of Rosuvastatin can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Rosuvastatin.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Rosuvastatin.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Rosuvastatin.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Rosuvastatin.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Rosuvastatin.]
[B01AC27, selexipag, The excretion of Selexipag can be decreased when combined with Rosuvastatin.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be increased when used in combination with Rosuvastatin.]
[M04AB05, lesinurad, The metabolism of Rosuvastatin can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[N05CA05, aprobarbital, The metabolism of Rosuvastatin can be increased when combined with Aprobarbital.]
[A02AB06, aloglutamol, Aloglutamol can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Rosuvastatin.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Rosuvastatin.]
[N04BC01, bromocriptine, The therapeutic efficacy of Bromocriptine can be increased when used in combination with Rosuvastatin.]
[A02AD05, aluminum magnesium silicate, Almasilate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AB03, aluminum phosphate, Aluminium phosphate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Rosuvastatin.]
[C03CA02, bumetanide, The excretion of Rosuvastatin can be decreased when combined with Bumetanide.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[N05BE01, buspirone, The metabolism of Rosuvastatin can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Rosuvastatin.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Rosuvastatin.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Rosuvastatin can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[S01AA26, azithromycin, The metabolism of Rosuvastatin can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Rosuvastatin can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Rosuvastatin.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A10BX06, benfluorex, The therapeutic efficacy of Benfluorex can be increased when used in combination with Rosuvastatin.]
[D05AX03, calcitriol, The metabolism of Rosuvastatin can be increased when combined with Calcitriol.]
[A12AA04, calcium carbonate, Calcium carbonate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01XX08, linezolid, The excretion of Rosuvastatin can be decreased when combined with Linezolid.]
[J05AE09, tipranavir, The serum concentration of Rosuvastatin can be increased when it is combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Rosuvastatin.]
[L04AB02, infliximab, The metabolism of Rosuvastatin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Rosuvastatin can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Rosuvastatin.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L04AC14, sarilumab, The metabolism of Rosuvastatin can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Rosuvastatin can be increased when combined with Delafloxacin.]
[D01AC10, bifonazole, The metabolism of Rosuvastatin can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, The metabolism of Rosuvastatin can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Rosuvastatin.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Rosuvastatin.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Rosuvastatin.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Rosuvastatin.]
[A02BX12, bismuth subnitrate, Bismuth subnitrate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AG03, efavirenz, The metabolism of Rosuvastatin can be decreased when combined with Efavirenz.]
[V03AB23, acetylcysteine, The excretion of Rosuvastatin can be decreased when combined with Acetylcysteine.]
[R03BA02, budesonide, Rosuvastatin may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Rosuvastatin.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A10BJ06, semaglutide, The therapeutic efficacy of Semaglutide can be increased when used in combination with Rosuvastatin.]
[N01BX04, capsaicin, The metabolism of Rosuvastatin can be decreased when combined with Capsaicin.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Rosuvastatin.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Rosuvastatin.]
[L02BB05, apalutamide, The metabolism of Rosuvastatin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Rosuvastatin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Rosuvastatin.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Rosuvastatin.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[B02BX08, avatrombopag, The excretion of Rosuvastatin can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Rosuvastatin.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Rosuvastatin.]
[H01CC03, elagolix, The excretion of Elagolix can be decreased when combined with Rosuvastatin.]
[L01XX62, ivosidenib, The metabolism of Rosuvastatin can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Rosuvastatin can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Rosuvastatin can be increased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Rosuvastatin.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Rosuvastatin.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Rosuvastatin.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be increased when used in combination with Rosuvastatin.]
[N01BA04, chloroprocaine, The therapeutic efficacy of Rosuvastatin can be decreased when used in combination with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Rosuvastatin.]
[R03BB08, revefenacin, Rosuvastatin may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Rosuvastatin can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Rosuvastatin can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Rosuvastatin.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofibrate is combined with Rosuvastatin.]
[P02BX04, triclabendazole, The metabolism of Rosuvastatin can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Rosuvastatin can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Rosuvastatin.]
[J01FA09, clarithromycin, The metabolism of Rosuvastatin can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Rosuvastatin.]
[N05BA09, clobazam, The metabolism of Rosuvastatin can be increased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Rosuvastatin can be increased when combined with Cloprednol.]
[C01EB09, ubidecarenone, The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Rosuvastatin.]
[C09CA06, candesartan, The excretion of Rosuvastatin can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Rosuvastatin can be increased when combined with Etanercept.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02AB17, cortivazol, The metabolism of Rosuvastatin can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Rosuvastatin can be decreased when it is combined with Alpelisib.]
[J01DC04, cefaclor, The excretion of Rosuvastatin can be decreased when combined with Cefaclor.]
[J01DB05, cefadroxil, The excretion of Rosuvastatin can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Rosuvastatin can be decreased when combined with Cefamandole.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Rosuvastatin.]
[L02BB06, darolutamide, The serum concentration of Rosuvastatin can be increased when it is combined with Darolutamide.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Rosuvastatin.]
[J01DD12, cefoperazone, The excretion of Rosuvastatin can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Rosuvastatin can be decreased when combined with Cefotaxime.]
[J01DC07, cefotiam, The excretion of Rosuvastatin can be decreased when combined with Cefotiam.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Rosuvastatin.]
[J01DD04, ceftriaxone, The excretion of Rosuvastatin can be decreased when combined with Ceftriaxone.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Rosuvastatin.]
[N07XX11, pitolisant, The serum concentration of Rosuvastatin can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Rosuvastatin.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Rosuvastatin.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Rosuvastatin is combined with Insulin pork.]
[J01XX09, daptomycin, The risk or severity of myopathy can be increased when Rosuvastatin is combined with Daptomycin.]
[J01DB01, cephalexin, The excretion of Rosuvastatin can be decreased when combined with Cephalexin.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Rosuvastatin.]
[J01DB03, cephalothin, The excretion of Rosuvastatin can be decreased when combined with Cefalotin.]
[J01DB09, cephradine, The metabolism of Rosuvastatin can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Rosuvastatin can be increased when combined with Deflazacort.]
[G03DB05, demegestone, Rosuvastatin may decrease the excretion rate of Demegestone which could result in a higher serum level.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Rosuvastatin.]
[N02CC08, lasmiditan, The serum concentration of Rosuvastatin can be increased when it is combined with Lasmiditan.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Rosuvastatin.]
[G03AC09, desogestrel, Rosuvastatin may decrease the excretion rate of Desogestrel which could result in a higher serum level.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Rosuvastatin.]
[N03AX25, cenobamate, The serum concentration of Rosuvastatin can be decreased when it is combined with Cenobamate.]
[L01EX18, avapritinib, The metabolism of Rosuvastatin can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Rosuvastatin.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Rosuvastatin.]
[M01AX21, diacetylrhein, The metabolism of Rosuvastatin can be decreased when combined with Diacerein.]
[C10AX15, bempedoic acid, The excretion of Rosuvastatin can be decreased when combined with Bempedoic acid.]
[J05AB16, remdesivir, The metabolism of Rosuvastatin can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Rosuvastatin can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Rosuvastatin can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Rosuvastatin.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Rosuvastatin.]
[G03DB08, dienogest, Rosuvastatin may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, The metabolism of Rosuvastatin can be decreased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Rosuvastatin can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Rosuvastatin can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Rosuvastatin can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Rosuvastatin can be increased when it is combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Rosuvastatin can be decreased when combined with Dirithromycin.]
[V03AE03, lanthanum carbonate, The absorption of Rosuvastatin can be decreased when combined with Lanthanum carbonate.]
[S03AA08, chloramphenicol, The metabolism of Rosuvastatin can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Rosuvastatin.]
[L01EX17, capmatinib, The serum concentration of Rosuvastatin can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The metabolism of Rosuvastatin can be increased when combined with Fluprednidene.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[M02AA27, dexketoprofen, The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Rosuvastatin.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Rosuvastatin.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Rosuvastatin.]
[J05AX29, fostemsavir, The serum concentration of Rosuvastatin can be increased when it is combined with Fostemsavir.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Rosuvastatin.]
[L01FX15, belantamab mafodotin, Rosuvastatin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.]
[L04AC19, satralizumab, The serum concentration of Rosuvastatin can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Rosuvastatin.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Rosuvastatin.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Rosuvastatin.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Rosuvastatin.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AB08, etodolac, The metabolism of Rosuvastatin can be decreased when combined with Etodolac.]
[C10AB09, etofibrate, The risk or severity of myopathy and rhabdomyolysis can be increased when Etofibrate is combined with Rosuvastatin.]
[B06AC06, berotralstat, The metabolism of Rosuvastatin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Rosuvastatin can be increased when it is combined with Lonafarnib.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Rosuvastatin.]
[J05AJ04, cabotegravir, The excretion of Rosuvastatin can be decreased when combined with Cabotegravir.]
[P03AX07, abametapir, The serum concentration of Rosuvastatin can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The metabolism of Rosuvastatin can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Rosuvastatin can be decreased when combined with Felbamate.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Rosuvastatin.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Rosuvastatin.]
[R03BA03, flunisolide, The metabolism of Rosuvastatin can be increased when combined with Flunisolide.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Rosuvastatin.]
[R03CC15, formoterol, The metabolism of Rosuvastatin can be decreased when combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Rosuvastatin is combined with Insulin human.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Rosuvastatin.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The metabolism of Rosuvastatin can be increased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Rosuvastatin can be decreased when combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Rosuvastatin can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Rosuvastatin.]
[S03AA07, ciprofloxacin, The metabolism of Rosuvastatin can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The metabolism of Rosuvastatin can be decreased when combined with Citalopram.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[P01CA03, fexinidazole, The excretion of Rosuvastatin can be decreased when combined with Fexinidazole.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Rosuvastatin.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Rosuvastatin.]
[L04AA59, avacopan, The metabolism of Rosuvastatin can be decreased when combined with Avacopan.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be increased when used in combination with Rosuvastatin.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be increased when used in combination with Rosuvastatin.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Rosuvastatin.]
[N06AX25, St. John's wort extract, The serum concentration of Rosuvastatin can be decreased when it is combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Rosuvastatin can be decreased when combined with Asciminib.]
[J05AX10, maribavir, The serum concentration of Rosuvastatin can be increased when it is combined with Maribavir.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Rosuvastatin.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[C10AB01, clofibrate, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Rosuvastatin.]
[B06AX04, mitapivat, The metabolism of Rosuvastatin can be increased when combined with Mitapivat.]
[L01EJ03, pacritinib, The serum concentration of Rosuvastatin can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Rosuvastatin.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Rosuvastatin.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Rosuvastatin.]
[C01EB24, mavacamten, The serum concentration of Rosuvastatin can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Rosuvastatin.]
[A10BX16, tirzepatide, The therapeutic efficacy of Tirzepatide can be increased when used in combination with Rosuvastatin.]
[J02AC06, oteseconazole, The serum concentration of Rosuvastatin can be increased when it is combined with Oteseconazole.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Rosuvastatin.]
[A05BA08, glycyrrhizic acid, Rosuvastatin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.]
[A04AA01, ondansetron, The metabolism of Rosuvastatin can be decreased when combined with Ondansetron.]
[N05AH02, clozapine, The metabolism of Rosuvastatin can be decreased when combined with Clozapine.]
[A10BX01, guar gum, The therapeutic efficacy of Guar gum can be increased when used in combination with Rosuvastatin.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Rosuvastatin can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Rosuvastatin can be increased when combined with Bimekizumab.]
[M04AC01, colchicine, Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA13, leflunomide, The serum concentration of Rosuvastatin can be increased when it is combined with Leflunomide.]
[A02AD04, hydrotalcite, Hydrotalcite can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10BX03, nateglinide, The therapeutic efficacy of Nateglinide can be increased when used in combination with Rosuvastatin.]
[H01AC03, mecasermin, The therapeutic efficacy of Mecasermin can be increased when used in combination with Rosuvastatin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Rosuvastatin is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Rosuvastatin can be decreased when combined with Telithromycin.]
[M01AH03, valdecoxib, The metabolism of Rosuvastatin can be decreased when combined with Valdecoxib.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Rosuvastatin.]
[J02AC02, itraconazole, The metabolism of Rosuvastatin can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The excretion of Rosuvastatin can be decreased when combined with Acyclovir.]
[N05BA10, ketazolam, The metabolism of Rosuvastatin can be decreased when combined with Ketazolam.]
[L01EA01, imatinib, The metabolism of Rosuvastatin can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Rosuvastatin can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The excretion of Rosuvastatin can be decreased when combined with Esomeprazole.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Rosuvastatin.]
[S01BA03, cortisone, The metabolism of Rosuvastatin can be increased when combined with Cortisone.]
[R06AX13, loratadine, Loratadine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A02AD02, magaldrate, Magaldrate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AD01, magnesium carbonate, Magnesium carbonate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CA11, manidipine, The metabolism of Rosuvastatin can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Mebeverine.]
[H02AB15, meprednisone, The metabolism of Rosuvastatin can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Rosuvastatin can be decreased when combined with Mequitazine.]
[R06AE03, cyclizine, The metabolism of Rosuvastatin can be decreased when combined with Cyclizine.]
[C03DA04, eplerenone, The metabolism of Rosuvastatin can be decreased when combined with Eplerenone.]
[J01FA03, midecamycin, The metabolism of Rosuvastatin can be decreased when combined with Midecamycin.]
[A10BF02, miglitol, The therapeutic efficacy of Miglitol can be increased when used in combination with Rosuvastatin.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Rosuvastatin.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Rosuvastatin.]
[S01XA18, cyclosporine, The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.]
[N06BA07, modafinil, The metabolism of Rosuvastatin can be increased when combined with Modafinil.]
[S01AA13, fusidic acid, The risk or severity of rhabdomyolysis can be increased when Fusidic acid is combined with Rosuvastatin.]
[S02BA08, fluocinolone acetonide, The metabolism of Rosuvastatin can be increased when combined with Fluocinolone acetonide.]
[M01AG01, mefenamic acid, The metabolism of Rosuvastatin can be decreased when combined with Mefenamic acid.]
[C03XA02, conivaptan, The metabolism of Rosuvastatin can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Rosuvastatin.]
[G04BE09, vardenafil, The metabolism of Rosuvastatin can be decreased when combined with Vardenafil.]
[M01AH05, etoricoxib, The metabolism of Rosuvastatin can be decreased when combined with Etoricoxib.]
[G03XA01, danazol, The serum concentration of Rosuvastatin can be increased when it is combined with Danazol.]
[J04BA02, dapsone, The metabolism of Rosuvastatin can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, Daunorubicin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A04AD11, nabilone, The metabolism of Rosuvastatin can be decreased when combined with Nabilone.]
[M01AX01, nabumetone, The metabolism of Rosuvastatin can be decreased when combined with Nabumetone.]
[N06AX06, nefazodone, The metabolism of Rosuvastatin can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Rosuvastatin can be decreased when combined with Nilutamide.]
[N06AA01, desipramine, The metabolism of Rosuvastatin can be decreased when combined with Desipramine.]
[N03AF02, oxcarbazepine, The metabolism of Rosuvastatin can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Rosuvastatin can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Rosuvastatin can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Rosuvastatin can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[R05DA09, dextromethorphan, The metabolism of Rosuvastatin can be decreased when combined with Dextromethorphan.]
[N03AC01, paramethadione, The metabolism of Rosuvastatin can be decreased when combined with Paramethadione.]
[N06AB05, paroxetine, The metabolism of Rosuvastatin can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Rosuvastatin can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Rosuvastatin can be decreased when combined with Diazepam.]
[S01BC03, diclofenac, The excretion of Rosuvastatin can be decreased when combined with Diclofenac.]
[J01CF01, dicloxacillin, The metabolism of Rosuvastatin can be increased when combined with Dicloxacillin.]
[A10BG03, pioglitazone, The therapeutic efficacy of Pioglitazone can be increased when used in combination with Rosuvastatin.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Rosuvastatin.]
[L01EB02, erlotinib, The metabolism of Rosuvastatin can be decreased when combined with Erlotinib.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[C08CA03, isradipine, The metabolism of Rosuvastatin can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Rosuvastatin can be increased when combined with Difluocortolone.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Rosuvastatin.]
[C01AA05, digoxin, Digoxin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[C04AE04, dihydroergocristine, Rosuvastatin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Rosuvastatin.]
[N02AA03, hydromorphone, The metabolism of Rosuvastatin can be decreased when combined with Hydromorphone.]
[J05AE08, atazanavir, The serum concentration of Rosuvastatin can be increased when it is combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Rosuvastatin can be decreased when combined with Treprostinil.]
[C08DB01, diltiazem, The metabolism of Rosuvastatin can be decreased when combined with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Rosuvastatin can be decreased when combined with Dimethyl sulfoxide.]
[G02AD02, dinoprostone, The excretion of Rosuvastatin can be decreased when combined with Dinoprostone.]
[C05CA03, diosmin, The metabolism of Rosuvastatin can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, The metabolism of Rosuvastatin can be decreased when combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Rosuvastatin.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Rosuvastatin.]
[B01AC07, dipyridamole, Dipyridamole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A03FA02, cisapride, The metabolism of Rosuvastatin can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Rosuvastatin.]
[C01BA03, disopyramide, The therapeutic efficacy of Disopyramide can be increased when used in combination with Rosuvastatin.]
[P03AA04, disulfiram, Disulfiram may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[S02AA12, rifamycin SV, The metabolism of Rosuvastatin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Rosuvastatin can be increased when combined with Rifapentine.]
[N05AX08, risperidone, The metabolism of Rosuvastatin can be decreased when combined with Risperidone.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Rosuvastatin.]
[A04AD12, aprepitant, The metabolism of Rosuvastatin can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Rosuvastatin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Rosuvastatin.]
[J05AE07, fosamprenavir, The serum concentration of Rosuvastatin can be increased when it is combined with Fosamprenavir.]
[G04BE08, tadalafil, The metabolism of Rosuvastatin can be decreased when combined with Tadalafil.]
[S01BC05, ketorolac, The metabolism of Rosuvastatin can be decreased when combined with Ketorolac.]
[C02KX02, ambrisentan, The excretion of Ambrisentan can be decreased when combined with Rosuvastatin.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Rosuvastatin.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Rosuvastatin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Rosuvastatin.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Rosuvastatin.]
[N06AB06, sertraline, The metabolism of Rosuvastatin can be decreased when combined with Sertraline.]
[C10AA01, simvastatin, Simvastatin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[B05XA02, sodium bicarbonate, Sodium bicarbonate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02CC01, sumatriptan, The excretion of Sumatriptan can be decreased when combined with Rosuvastatin.]
[H01AA01, corticotropin, The metabolism of Rosuvastatin can be increased when combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Rosuvastatin.]
[M01AC02, tenoxicam, The excretion of Rosuvastatin can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Rosuvastatin.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Emetine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Rosuvastatin.]
[C09AA02, enalapril, The excretion of Rosuvastatin can be decreased when combined with Enalapril.]
[N03AX11, topiramate, The metabolism of Rosuvastatin can be increased when combined with Topiramate.]
[C03CA04, torsemide, The metabolism of Rosuvastatin can be decreased when combined with Torasemide.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Rosuvastatin.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Rosuvastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The metabolism of Rosuvastatin can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Rosuvastatin can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, The metabolism of Rosuvastatin can be decreased when combined with Zolpidem.]
[N03AX15, zonisamide, The metabolism of Rosuvastatin can be decreased when combined with Zonisamide.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Rosuvastatin is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Rosuvastatin.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Iloprost is combined with Rosuvastatin.]
[N02CA02, ergotamine, The metabolism of Rosuvastatin can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The serum concentration of Rosuvastatin can be decreased when it is combined with Erythromycin.]
[A02BC02, pantoprazole, The excretion of Rosuvastatin can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, Rosuvastatin may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Rosuvastatin can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Rosuvastatin can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Rosuvastatin can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Rosuvastatin can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fluvastatin is combined with Rosuvastatin.]
[L02AA03, ethinyl estradiol, Rosuvastatin may decrease the excretion rate of Ethinylestradiol which could result in a higher serum level.]
[M01AC06, meloxicam, The metabolism of Rosuvastatin can be decreased when combined with Meloxicam.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Rosuvastatin.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Rosuvastatin.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Rosuvastatin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Rosuvastatin.]
[R06AX12, terfenadine, The metabolism of Rosuvastatin can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Rosuvastatin.]
[N06AB08, fluvoxamine, The metabolism of Rosuvastatin can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Rosuvastatin.]
[C10AA03, pravastatin, The excretion of Rosuvastatin can be decreased when combined with Pravastatin.]
[D11AX24, deoxycholic acid, Deoxycholic acid may increase the excretion rate of Rosuvastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BA03, famotidine, The excretion of Rosuvastatin can be decreased when combined with Famotidine.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Rosuvastatin.]
[P02CA03, albendazole, The metabolism of Rosuvastatin can be decreased when combined with Albendazole.]
[C08CA02, felodipine, Felodipine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Rosuvastatin.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Rosuvastatin.]
[C01BC04, flecainide, The metabolism of Rosuvastatin can be decreased when combined with Flecainide.]
[J01CF05, floxacillin, Flucloxacillin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Rosuvastatin can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Rosuvastatin.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Rosuvastatin.]
[D07AC08, fluocinonide, The metabolism of Rosuvastatin can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Rosuvastatin can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ethanol is combined with Rosuvastatin.]
[L01BC09, floxuridine, The metabolism of Rosuvastatin can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Rosuvastatin can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The metabolism of Rosuvastatin can be decreased when combined with Fluoxetine.]
[S01BC04, flurbiprofen, The metabolism of Rosuvastatin can be decreased when combined with Flurbiprofen.]
[L02BB01, flutamide, The metabolism of Rosuvastatin can be decreased when combined with Flutamide.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Rosuvastatin.]
[J05AE10, darunavir, The serum concentration of Rosuvastatin can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The excretion of Rosuvastatin can be decreased when combined with Furosemide.]
[S01AD09, ganciclovir, The excretion of Rosuvastatin can be decreased when combined with Ganciclovir.]
[N03AA04, barbexaclone, The metabolism of Rosuvastatin can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The serum concentration of Rosuvastatin can be increased when it is combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Rosuvastatin.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Rosuvastatin.]
[A10BJ02, liraglutide, The therapeutic efficacy of Liraglutide can be increased when used in combination with Rosuvastatin.]
[J05AG04, etravirine, The metabolism of Rosuvastatin can be increased when combined with Etravirine.]
[G03XA02, gestrinone, Rosuvastatin may decrease the excretion rate of Gestrinone which could result in a higher serum level.]
[N01AH02, alfentanil, The metabolism of Rosuvastatin can be decreased when combined with Alfentanil.]
[L01EH01, lapatinib, The metabolism of Rosuvastatin can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, Glyburide may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be increased when used in combination with Rosuvastatin.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be increased when used in combination with Rosuvastatin.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Rosuvastatin.]
[C02CA04, doxazosin, The metabolism of Rosuvastatin can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Rosuvastatin.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Rosuvastatin is combined with Fluindione.]
[D01BA01, griseofulvin, The metabolism of Rosuvastatin can be increased when combined with Griseofulvin.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Rosuvastatin.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Rosuvastatin.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Rosuvastatin.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Rosuvastatin.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Rosuvastatin is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Rosuvastatin.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Rosuvastatin.]
[C09CA01, losartan, Losartan may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Rosuvastatin.]
[A07EC02, mesalamine, The excretion of Mesalazine can be decreased when combined with Rosuvastatin.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Rosuvastatin.]
[J05AG01, nevirapine, The metabolism of Rosuvastatin can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Rosuvastatin can be decreased when combined with Nilvadipine.]
[C02DB02, hydralazine, The metabolism of Rosuvastatin can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Rosuvastatin.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Rosuvastatin.]
[N05BB01, hydroxyzine, The metabolism of Rosuvastatin can be decreased when combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Rosuvastatin can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Rosuvastatin.]
[R02AX02, ibuprofen, The excretion of Rosuvastatin can be decreased when combined with Ibuprofen.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Rosuvastatin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Rosuvastatin.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Rosuvastatin.]
[S01BC01, indomethacin, The excretion of Rosuvastatin can be decreased when combined with Indomethacin.]
[N06AX17, milnacipran, The metabolism of Rosuvastatin can be decreased when combined with Milnacipran.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Cyclopentamine.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Rosuvastatin.]
[N05BA12, alprazolam, The metabolism of Rosuvastatin can be decreased when combined with Alprazolam.]
[N05CH02, ramelteon, The metabolism of Rosuvastatin can be decreased when combined with Ramelteon.]
[A10BH02, vildagliptin, The therapeutic efficacy of Vildagliptin can be increased when used in combination with Rosuvastatin.]
[C10AA06, cerivastatin, Cerivastatin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Rosuvastatin.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Rosuvastatin.]
[N06AF05, iproniazid, The metabolism of Rosuvastatin can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Rosuvastatin can be decreased when combined with Atovaquone.]
[J04AC01, isoniazid, The metabolism of Rosuvastatin can be decreased when combined with Isoniazid.]
[A10BJ01, exenatide, The therapeutic efficacy of Exenatide can be increased when used in combination with Rosuvastatin.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Rosuvastatin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Rosuvastatin.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Rosuvastatin.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC07, tocilizumab, The metabolism of Rosuvastatin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Rosuvastatin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Rosuvastatin.]
[J02AB02, ketoconazole, The metabolism of Rosuvastatin can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Rosuvastatin can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of adverse effects can be increased when Ketoprofen is combined with Rosuvastatin.]
[V03AC03, deferasirox, The metabolism of Rosuvastatin can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Rosuvastatin can be increased when combined with Abatacept.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Rosuvastatin.]
[G03AD01, levonorgestrel, Rosuvastatin may decrease the excretion rate of Levonorgestrel which could result in a higher serum level.]
[S02DA01, lidocaine, The metabolism of Rosuvastatin can be decreased when combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Rosuvastatin can be increased when combined with Armodafinil.]
[C10AA02, lovastatin, The metabolism of Rosuvastatin can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, Rosuvastatin may decrease the excretion rate of Lynestrenol which could result in a higher serum level.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Rosuvastatin.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC10, magnesium oxide, Magnesium oxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EA03, nilotinib, The metabolism of Rosuvastatin can be decreased when combined with Nilotinib.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Mecamylamine.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Rosuvastatin.]
[N05CH01, melatonin, The excretion of Rosuvastatin can be decreased when combined with Melatonin.]
[N02AB02, meperidine, The metabolism of Rosuvastatin can be decreased when combined with Meperidine.]
[N03AB04, mephenytoin, The metabolism of Rosuvastatin can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, The metabolism of Rosuvastatin can be increased when combined with Methylphenobarbital.]
[L02BG01, aminoglutethimide, The metabolism of Rosuvastatin can be increased when combined with Aminoglutethimide.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Rosuvastatin.]
[A10BA02, metformin, Metformin may increase the hypolipidaemic activities of Rosuvastatin.]
[H01CB03, lanreotide, The metabolism of Rosuvastatin can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Rosuvastatin can be decreased when combined with Methadone.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Rosuvastatin.]
[H03BB02, methimazole, The metabolism of Rosuvastatin can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Rosuvastatin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Methotrexate.]
[N02BG09, methoxyflurane, The metabolism of Rosuvastatin can be decreased when combined with Methoxyflurane.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Rosuvastatin.]
[V04CG05, methylene blue, The metabolism of Rosuvastatin can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Rosuvastatin can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Rosuvastatin.]
[H02AB04, methylprednisolone, The metabolism of Rosuvastatin can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Rosuvastatin can be increased when combined with Rufinamide.]
[G03EK01, methyltestosterone, The excretion of Rosuvastatin can be increased when combined with Methyltestosterone.]
[N02CA04, methysergide, The metabolism of Rosuvastatin can be decreased when combined with Methysergide.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Metoclopramide.]
[P01AB01, metronidazole, The metabolism of Rosuvastatin can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Rosuvastatin can be increased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Rosuvastatin can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Rosuvastatin.]
[N05CD08, midazolam, The metabolism of Rosuvastatin can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, Rosuvastatin may decrease the excretion rate of Mifepristone which could result in a higher serum level.]
[J01AA08, minocycline, The excretion of Rosuvastatin can be decreased when combined with Minocycline.]
[J01FA11, miocamycin, The metabolism of Rosuvastatin can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Rosuvastatin can be increased when combined with Mitotane.]
[L03AC01, aldesleukin, The metabolism of Rosuvastatin can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Rosuvastatin can be increased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Rosuvastatin can be decreased when combined with Amitriptyline.]
[L04AB05, certolizumab pegol, The metabolism of Rosuvastatin can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The serum concentration of Rosuvastatin can be increased when it is combined with Eltrombopag.]
[L01EX03, pazopanib, Rosuvastatin may increase the hepatotoxic activities of Pazopanib.]
[N05CA02, amobarbital, The metabolism of Rosuvastatin can be increased when combined with Amobarbital.]
[J05AJ01, raltegravir, The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Rosuvastatin.]
[P01BA06, amodiaquine, The metabolism of Rosuvastatin can be decreased when combined with Amodiaquine.]
[G03XC01, raloxifene, The metabolism of Rosuvastatin can be decreased when combined with Raloxifene.]
[N03AB05, fosphenytoin, The metabolism of Rosuvastatin can be increased when combined with Fosphenytoin.]
[J01CF06, nafcillin, The metabolism of Rosuvastatin can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Rosuvastatin can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Rosuvastatin.]
[L04AC03, anakinra, The metabolism of Rosuvastatin can be increased when combined with Anakinra.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[A10BG01, troglitazone, Troglitazone may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[N06AX21, duloxetine, The metabolism of Rosuvastatin can be decreased when combined with Duloxetine.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Rosuvastatin.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Letrozole is combined with Rosuvastatin.]
[A10BX02, repaglinide, The therapeutic efficacy of Repaglinide can be increased when used in combination with Rosuvastatin.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Rosuvastatin.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Rosuvastatin.]
[N06AX23, desvenlafaxine, The metabolism of Rosuvastatin can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Rosuvastatin.]
[M04AA03, febuxostat, The excretion of Rosuvastatin can be decreased when combined with Febuxostat.]
[C10AD02, niacin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Rosuvastatin.]
[C08CA04, nicardipine, The metabolism of Rosuvastatin can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Rosuvastatin.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Nicotine.]
[C08CA05, nifedipine, Rosuvastatin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[C08CA07, nisoldipine, The metabolism of Rosuvastatin can be decreased when combined with Nisoldipine.]
[C08CA08, nitrendipine, Nitrendipine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[N05CF03, zaleplon, The metabolism of Rosuvastatin can be decreased when combined with Zaleplon.]
[G03DC02, norethindrone, Rosuvastatin may decrease the excretion rate of Norethisterone which could result in a higher serum level.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Norfloxacin is combined with Rosuvastatin.]
[G03AC07, norgestrienone, Rosuvastatin may decrease the excretion rate of Norgestrienone which could result in a higher serum level.]
[C02KX01, bosentan, The serum concentration of Rosuvastatin can be decreased when it is combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Rosuvastatin.]
[R05DA07, noscapine, The metabolism of Rosuvastatin can be decreased when combined with Noscapine.]
[G01AA01, nystatin, The excretion of Rosuvastatin can be decreased when combined with Nystatin.]
[H01CB02, octreotide, The metabolism of Rosuvastatin can be decreased when combined with Octreotide.]
[S02AA16, ofloxacin, Rosuvastatin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.]
[J01FA05, oleandomycin, The metabolism of Rosuvastatin can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Rosuvastatin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[C01AC01, ouabain, The excretion of Rosuvastatin can be decreased when combined with Ouabain.]
[A14AA08, oxandrolone, The metabolism of Rosuvastatin can be decreased when combined with Oxandrolone.]
[N02AA05, oxycodone, The metabolism of Rosuvastatin can be decreased when combined with Oxycodone.]
[S01AA04, oxytetracycline, The excretion of Rosuvastatin can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The excretion of Rosuvastatin can be decreased when combined with Aminohippuric acid.]
[G03DB06, chlormadinone, Rosuvastatin may decrease the excretion rate of Chlormadinone which could result in a higher serum level.]
[H02AB05, paramethasone, The metabolism of Rosuvastatin can be increased when combined with Paramethasone.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Rosuvastatin.]
[S01AA14, penicillin G, Rosuvastatin may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Rosuvastatin can be increased when combined with Pentobarbital.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Rosuvastatin.]
[A10BA01, phenformin, The therapeutic efficacy of Phenformin can be increased when used in combination with Rosuvastatin.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Rosuvastatin is combined with Phenindione.]
[N03AA02, phenobarbital, The metabolism of Rosuvastatin can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Rosuvastatin.]
[M02AA01, phenylbutazone, The excretion of Rosuvastatin can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Rosuvastatin can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Rosuvastatin can be increased when combined with Golimumab.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Rosuvastatin.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Rosuvastatin.]
[C08CX01, mibefradil, The metabolism of Rosuvastatin can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Rosuvastatin.]
[C10AA05, atorvastatin, Atorvastatin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Rosuvastatin.]
[J05AE01, saquinavir, The metabolism of Rosuvastatin can be decreased when combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Rosuvastatin.]
[S01BC06, piroxicam, The excretion of Rosuvastatin can be decreased when combined with Piroxicam.]
[J05AG02, delavirdine, The metabolism of Rosuvastatin can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Rosuvastatin can be decreased when combined with Irbesartan.]
[A10BG02, rosiglitazone, The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Rosuvastatin.]
[A03AE01, alosetron, The metabolism of Rosuvastatin can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Rosuvastatin can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Rosuvastatin.]
[J05AE03, ritonavir, The serum concentration of Rosuvastatin can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Rosuvastatin.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Rosuvastatin is combined with Insulin lispro.]
[C10AA08, pitavastatin, Rosuvastatin may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[P02BA01, praziquantel, The metabolism of Rosuvastatin can be decreased when combined with Praziquantel.]
[S03BA02, prednisolone, The metabolism of Rosuvastatin can be increased when combined with Prednisolone.]
[P01BA03, primaquine, The metabolism of Rosuvastatin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Rosuvastatin can be increased when combined with Primidone.]
[M04AB01, probenecid, The excretion of Rosuvastatin can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procainamide is combined with Rosuvastatin.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Procarbazine.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[N05AA03, promazine, The metabolism of Rosuvastatin can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Rosuvastatin can be decreased when combined with Promethazine.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Rosuvastatin.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Rosuvastatin.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propofol is combined with Rosuvastatin.]
[N02AC04, propoxyphene, The metabolism of Rosuvastatin can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Rosuvastatin can be decreased when combined with Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Rosuvastatin.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Rosuvastatin.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Rosuvastatin.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Rosuvastatin.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Rosuvastatin.]
[P01BC01, quinine, The therapeutic efficacy of Quinine can be increased when used in combination with Rosuvastatin.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Rosuvastatin.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Rosuvastatin can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The excretion of Rosuvastatin can be decreased when combined with Roxithromycin.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[S01BC08, salicylic acid, The excretion of Rosuvastatin can be decreased when combined with Salicylic acid.]
[N05CA06, secobarbital, The metabolism of Rosuvastatin can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Rosuvastatin can be decreased when combined with Selegiline.]
[H01CB01, somatostatin, The metabolism of Rosuvastatin can be decreased when combined with Somatostatin.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Rosuvastatin.]
[C03DA01, spironolactone, Spironolactone may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[N03AG01, valproic acid, The excretion of Valproic acid can be decreased when combined with Rosuvastatin.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Rosuvastatin.]
[D07AB02, hydrocortisone butyrate, The metabolism of Rosuvastatin can be increased when combined with Hydrocortisone butyrate.]
[H02CA04, levoketoconazole, The metabolism of Rosuvastatin can be decreased when combined with Levoketoconazole.]
[A05AA02, ursodiol, Ursodeoxycholic acid may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
